市場調査レポート
商品コード
1400702
MRIの世界市場の評価:磁場強度別、設計別、用途別、エンドユーザー別、地域別、機会、予測(2017年~2031年)Magnetic Resonance Imaging Market Assessment, By Field Strength, By Design, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
MRIの世界市場の評価:磁場強度別、設計別、用途別、エンドユーザー別、地域別、機会、予測(2017年~2031年) |
出版日: 2024年01月03日
発行: Market Xcel - Markets and Data
ページ情報: 英文 228 Pages
納期: 3~5営業日
|
世界のMRIの市場規模は、2023年に74億米ドル、2031年に115億1,000万米ドルに達し、2024年~2031年の予測期間にCAGRで5.68%の成長が見込まれています。市場は近年、重大な要因の重なりと顕著な技術革新に後押しされ、大幅な成長を示しています。市場拡大の主な要因は、老年人口の増加、慢性疾患の罹患率の増加、新技術の導入、新興国における設置の増加と意識の高まりです。
コンピューターサイエンス、データ処理、半導体などのさまざまな分野の新技術が、MRI技術の進歩に急速に不可欠なものとなっています。この統合は、革新的な用途の創造につながっています。HPCとMRI技術の進歩の相乗効果により、MRIは現在、機能的および解剖学的な画像データの広範なセットを生成することができ、これは複数の疾患にわたる重要なリソースとして役立っています。MRI装置の高いコストやMRI検査技師の不足といった要因が、市場にマイナスの影響を与えています。
市場は、老年人口の増加と慢性疾患の罹患率の向上を主因として、大幅な成長を示しています。近年、老年人口が大幅に増加しており、診察や診断サービスを求める高齢者が増えています。高齢化に伴い、心血管疾患、がん、神経疾患などの慢性疾患を含むさまざまな健康問題への感受性が高まります。2030年までに、世界の6人に1人が60歳以上の高齢者となります。この期間、世界人口に占める60歳以上の高齢者の割合は、2020年の10億人から14億人に増加します。2050年に目を向けると、60歳以上の世界人口は倍増し、21億人に達すると予測されています。さらに、80歳以上の高齢者の数は2020年~2050年に3倍になり、4億2,600万人に達すると予測されています。MRI技術は、これらの疾患の早期発見、正確な診断、モニタリングに有用であることが証明されています。MRIは非侵襲で高解像度な画像診断が可能であるため、医療従事者に好まれています。MRIは、動脈瘤、眼/耳疾患、脳卒中、腫瘍、脳損傷、靭帯損傷などの疾患の発見に役立っています。その結果、医療提供者や患者が、患者の予後を改善し、より効率的な医療管理を支える技術の役割を認識するようになり、MRI技術に対する需要が急増しています。
MRI技術の進歩により、市場における技術革新が加速しています。高磁場MRIスキャナー、マルチパラメトリックイメージング、AIを活用した画像解析などの新たな開発により、画質と診断精度が大幅に向上しました。さらに、機能的MRI(fMRI)と拡散テンソルイメージング(DTI)の統合は、脳機能と結合性の理解における新たな可能性を引き出し、神経疾患の診断と治療に役立っています。さらに、MRI装置の小型化とポータブルシステムの登場により、この診断ツールは遠隔地や十分なサービスを受けていない地域でも利用しやすくなっています。
現在、高磁場強度MRIと超高磁場強度MRI技術が市場を独占しています。これらの先進のMRIシステムは高い画像解像度を提供し、より精密で詳細な診断を可能にします。一般的に1.5テスラまたは3テスラで動作する高磁場MRIは、さまざまな臨床用途の標準となっており、4テスラ以上で動作する超高磁場MRIは、研究や特殊な臨床現場で脚光を浴びています。これらの強力なMRIシステムは、ニューロイメージング、心血管の調査、神経疾患の研究に役立っており、以前は収集が困難だった貴重な知見を提供しています。高磁場強度での動作の主な利点は、S/N比の向上と化学シフトの強化です。高いS/N比は、診断の質を損なうことなくスキャン時間を短縮したり、空間分解能を高めたりするために利用できます。
MRI装置の設置は新興国で増加傾向にあり、医療インフラに大きな変化をもたらしています。この増加は、医療予算の増加、中間所得層の増加、早期の診断と治療における先進の医用画像の重要な役割の認識などの要因によるものと考えられます。さらに、さまざまな病状の検出やモニタリングにおけるMRIの利点について、医療従事者や市民の認識が高まっていることも、この拡大を後押ししています。MRIサービスが利用可能になることで、質の高い医療へのアクセスが向上し、より正確な診断と患者の転帰の改善が可能になります。この動向は、先進国と新興国の医療格差の解消に向けた前向きな一歩を反映しています。
当レポートでは、世界のMRI市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。
Global magnetic resonance imaging market size was valued at USD 7.4 billion in 2023, expected to reach USD 11.51 billion in 2031, with a CAGR of 5.68% for the forecast period between 2024 and 2031F. The global magnetic resonance imaging market has experienced substantial growth in recent years, driven by a convergence of key factors and fueled by remarkable innovations. Market expansion is primarily attributed to the growing geriatric population, increasing incidence of chronic diseases, introduction of novel technologies, and increasing installation and growing awareness in emerging countries.
Emerging technologies from different fields such as computer science, data processing, and semiconductors have quickly become integral to advancements in MRI technology. This integration has led to the creation of innovative applications. Through the synergies of high-performance computing and advancements in MRI technology, MRI can now generate extensive sets of both functional and anatomical image data, which serves as a vital resource across multiple diseases. Factors such as the high cost of MRI machines and the shortage of MRI technologists are negatively impacting the global magnetic resonance imaging (MRI) market.
The global magnetic resonance imaging market is experiencing substantial growth, largely driven by the growing geriatric population and the rising incidence of chronic diseases. The aging demographic has considerably increased in recent years, with more elderly individuals seeking medical attention and diagnostic services. As individuals age, their susceptibility to various health issues, including chronic diseases such as cardiovascular conditions, cancer, and neurological disorders, increases. By the year 2030, one out of every six individuals worldwide will have reached the age of 60 or older. During this period, the proportion of global population comprising those aged 60 and above will rise from 1 billion in 2020 to 1.4 billion. Looking ahead to 2050, the global population of individuals aged 60 and older is projected to double, reaching 2.1 billion. Furthermore, the number of people aged 80 or older is anticipated to triple between 2020 and 2050, reaching 426 million. MRI technology has proven valuable in the early disease detection, accurate diagnosis, and monitoring of these conditions. It offers non-invasive, high-resolution imaging, making it a preferred choice for healthcare professionals. MRI aids in detecting conditions such as aneurysm, eye/ear disorders, stroke, tumor, brain injuries, and ligament injuries. Consequently, the demand for MRI technologies has surged as healthcare providers and patients recognize technology's role in improving patient outcomes and ensuring more efficient healthcare management.
Advancements in MRI technologies have accelerated innovation in the global magnetic resonance imaging (MRI) market. Novel developments, such as higher-field MRI scanners, multi-parametric imaging, and AI-driven image analysis, have significantly improved image quality and diagnostic accuracy. Furthermore, the integration of functional MRI (fMRI) and diffusion tensor imaging (DTI) has unlocked new possibilities in understanding brain function and connectivity, aiding in the diagnosis and treatment of neurological conditions. Additionally, the miniaturization of MRI machines and the advent of portable systems have made this diagnostic tool more accessible, even in remote or underserved regions.
In September 2023, the FDA granted regulatory approval for IGAR, a robotics system created by Insight Medbotics, making it the first and only robotic platform specifically engineered to operate within the MRI bore. The pioneering technology, IGAR, has the potential for future adaptations to function in various hospital settings. Insight Medbotics has showcased the safety and effectiveness of IGAR through publicly available clinical studies focused on breast biopsy procedures.
At the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2023 Annual Meeting, GE Healthcare introduced its SIGNA PET/MR AIR. During the event, the company presented the incorporation of its state-of-the-art AIR technologies into the SIGNA PET/MR AIR system, aiming to improve diagnostic accuracy, streamline treatment assessment, and enhance the overall comfort of patients.
High field strength MRI and ultra-high field strength MRI technologies are currently dominating the MRI market. These advanced MRI systems offer high image resolution, allowing for more precise and detailed diagnosis. High field MRI, typically operating at 1.5 Tesla or 3 Tesla, has become the standard for various clinical applications, while ultra-high field MRI, operating beyond 4 Tesla or higher, is gaining prominence in research and specialized clinical settings. These powerful MRI systems are instrumental in neuroimaging, cardiovascular studies, and research into neurological disorders, providing invaluable insights that were previously difficult to gather. The primary benefits of operating at high field strengths include an increased signal-to-noise ratio and enhanced chemical shift. High signal-to-noise ratio can be used to either reduce scanning time without compromising diagnostic quality or to enhance spatial resolution.
In February 2023, A group of seven organizations, led by the Donders Institute of Brain, Cognition, and Behavior, has been awarded EUR 19 million roadmap grant from the Dutch Research Council. This funding will be dedicated to the development of the world's inaugural 14 Tesla MRI scanner. The heightened sensitivity of this scanner will enable researchers to achieve more comprehensive brain imaging, leading to an improved understanding of brain function. Additionally, it will provide fresh insights into disease mechanisms and their treatment across the entire human body.
The installation of MRI machines is on the rise in emerging countries, marking a significant shift in healthcare infrastructure. The increase can be attributed to several factors, including rising healthcare budgets, a growing middle-class population, and the recognition of the vital role that advanced medical imaging plays in early diagnosis and treatment. Additionally, the growing awareness among healthcare professionals and the public about the benefits of MRI in detecting and monitoring various medical conditions has driven this expansion. The availability of MRI services is improving access to high-quality healthcare, allowing for more accurate diagnosis and better patient outcomes. This trend reflects a positive step towards bridging the healthcare gap between developed and emerging nations.
The global magnetic resonance imaging (MRI) market experienced significant impacts due to the COVID-19 pandemic. Initially, as healthcare resources were diverted towards managing the pandemic, non-essential medical procedures, including elective MRI scans, were postponed or canceled to prioritize COVID-19 patients. It led to a temporary downturn in MRI utilization and revenue for many healthcare facilities. However, the pandemic highlighted the importance of advanced diagnostic imaging in healthcare. As COVID-19 cases surged, MRI played a crucial role in assessing the extent of lung damage and monitoring patients' conditions. Moreover, the awareness of the need for faster and more efficient MRI diagnosis for COVID-19-related complications led to innovations in MRI technology. In the post-COVID-19 era, there has been a notable surge in the utilization of AI and machine learning in MRI, revolutionizing the field of medical imaging. These technologies are enhancing diagnostic accuracy, automating image analysis, and expediting the interpretation of MRI scans.
The global magnetic resonance imaging market features a landscape dominated by key players such as GE Healthcare Technologies Inc., Canon Medical System Corporation, Koninklijke Philips N.V, Siemens Healthineers AG, Hitachi Ltd, Aurora Imaging Technologies Inc., Fujifilm Holdings Corporation, and others. Companies are enhancing their imaging capabilities by manufacturing MRI scanners that have ultra-high field strength by surpassing the old high field strength of 3 Tesla. Market players are designing MRI scanners that are open or have wide bore for patients that are claustrophobic. Market players are developing partnerships to reach emerging markets.
In September 2023, Siemens Healthineers announced the FDA approval of Magnetom Viato.Mobile, a novel 1.5 Tesla (1.5T) magnetic resonance (MR) imaging scanner. This MRI scanner is specially designed for mobile applications, offering increased versatility for deploying MR imaging. It can be conveniently set up on a trailer, facilitating transportation to remote locations, thus extending the accessibility of advanced medical imaging to patients, including those with significant health issues, who would otherwise face long journeys for such services.
In October 2023, Philips announced its collaboration with Quibim to introduce advanced AI-driven imaging software aimed at prostate cancer detection. By combining Philips' innovative AI-enhanced MR imaging software with Quibim's AI-powered image analysis software, healthcare providers can expedite and simplify prostate cancer diagnosis and care.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work